Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Mallinckrodt
Harvard Business School
Johnson and Johnson
AstraZeneca

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Cefotetan disodium - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Drug Prices for cefotetan disodium

See drug prices for cefotetan disodium

Recent Clinical Trials for cefotetan disodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all cefotetan disodium clinical trials

Pharmacology for cefotetan disodium
Medical Subject Heading (MeSH) Categories for cefotetan disodium
Synonyms for cefotetan disodium
(6R,7S)-4-((2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)-1,3-dithietane-delta(sup 2,alpha)-malonamic acid, disodium salt
(6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, disodium salt
0GXP746VXB
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethyl)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6R-cis)-
69712-56-7 (Parent)
74356-00-6
AC1L1E30
AKOS025311215
AN-37204
Apatef
C14007
C17H15N7O8S4.2Na
C17H17N7O8S4.2Na
Cefotan
Cefotan (TN)
CEFOTAN IN PLASTIC CONTAINER
Cefotetan and dextrose in duplex container
Cefotetan disodium (USP)
Cefotetan disodium [USAN:USP]
Cefotetan disodium [USAN]
Cefotetan disodium salt
Cefotetan disodium, Antibiotic for Culture Media Use Only
cefotetan sodium
Cefotetan sodium (JAN)
Ceftenon
Cepan
CHEBI:34617
CHEMBL1201098
D02228
Darvilen
disodium (6R,7S)-7-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium (6R,7S)-7-[[4-(1-amino-3-oxido-1,3-dioxopropan-2-ylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium (6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Disodium (7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium 7beta-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylate
Disodium(7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
EINECS 277-834-9
FT-0645368
ICI 156834 disodium
ICI-156834
LS-149943
M153
PubChem19005
SCHEMBL40794
sodium (6R,7S)-7-(4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
UNII-0GXP746VXB
Yamatetan
YM 09330
YM-09330

US Patents and Regulatory Information for cefotetan disodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma CEFOTETAN cefotetan disodium INJECTABLE;INJECTION 091031-002 Oct 26, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharm Corp CEFOTETAN cefotetan disodium INJECTABLE;INJECTION 091030-001 Oct 26, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
Teligent CEFOTAN cefotetan disodium INJECTABLE;INJECTION 050588-003 Apr 25, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Teligent Pharma Inc CEFOTAN cefotetan disodium INJECTABLE;INJECTION 063293-001 Apr 29, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Express Scripts
Harvard Business School
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.